Takeda Pharmaceutical
TAK
#368
Rank
โ‚ฌ60.18 B
Marketcap
18,84ย โ‚ฌ
Share price
0.45%
Change (1 day)
58.80%
Change (1 year)

EPS for Takeda Pharmaceutical (TAK)

EPS in 2023 (TTM): 0,43ย โ‚ฌ

According to Takeda Pharmaceutical's latest financial reports the company's current EPS (TTM) is 0,52ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of 0,58ย โ‚ฌ a decrease over its 2021 EPS that were of 1,12ย โ‚ฌ.

EPS history for Takeda Pharmaceutical from 2009 to 2023

Annual EPS

Year EPS Change
2023 (TTM)0,43ย โ‚ฌ-26.44%
20220,58ย โ‚ฌ-48.38%
20211,12ย โ‚ฌ129.33%
20200,49ย โ‚ฌ1194.61%
20190,03789ย โ‚ฌ-93.1%
20180,55ย โ‚ฌ-43.22%
20170,97ย โ‚ฌ33.37%
20160,73ย โ‚ฌ-236.78%
2015-0,53ย โ‚ฌ-294.41%
20140,27ย โ‚ฌ-66.04%
20130,80ย โ‚ฌ9.95%
20120,73ย โ‚ฌ-46.86%
20111,37ย โ‚ฌ-18.07%
20101,68ย โ‚ฌ-13.68%
20091,94ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
5,96ย โ‚ฌ 1,047.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
4,68ย โ‚ฌ 801.39%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
0,68ย โ‚ฌ 30.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
14,47ย โ‚ฌ 2,684.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
1,70ย โ‚ฌ 226.72%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
0,89ย โ‚ฌ 70.44%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
2,57ย โ‚ฌ 394.02%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
-3,58ย โ‚ฌ-788.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
0,32ย โ‚ฌ-37.83%๐Ÿ‡ฎ๐Ÿ‡ณ India